PHARMANOVIA Trademark

Trademark Overview


On Friday, December 4, 2020, a trademark application was filed for PHARMANOVIA with the United States Patent and Trademark Office. The USPTO has given the PHARMANOVIA trademark a serial number of 79301402. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by Atnahs Pharma UK Limited. The PHARMANOVIA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations, namely, antivirals, analgesic, antipyretic and anti-inflammatory preparations; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations for the prevention and treatment of cancer; cardiovascular pharmaceutical preparations; sanitary preparations for medical purposes; food for babies; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides

Surgical apparatus and instruments for medical, dental and veterinary use; artificial limbs, eyes and teeth; suture materials
pharmanovia

General Information


Serial Number79301402
Word MarkPHARMANOVIA
Filing DateFriday, December 4, 2020
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6914782
Registration DateTuesday, December 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations, namely, antivirals, analgesic, antipyretic and anti-inflammatory preparations; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations for the prevention and treatment of cancer; cardiovascular pharmaceutical preparations; sanitary preparations for medical purposes; food for babies; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides
Goods and ServicesSurgical apparatus and instruments for medical, dental and veterinary use; artificial limbs, eyes and teeth; suture materials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, January 14, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAtnahs Pharma UK Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGB

Party NameAtnahs Pharma UK Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGB

Party NameAtnahs Pharma UK Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGB

Trademark Events


Event DateEvent Description
Thursday, September 14, 2023INTERNATIONAL REGISTRATION RENEWED
Monday, April 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, April 16, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, March 24, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 23, 2023FINAL DISPOSITION PROCESSED
Monday, March 6, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Sunday, October 9, 2022NOTIFICATION PROCESSED BY IB
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 7, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 29, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, June 21, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 1, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 1, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, January 27, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, July 26, 2021LETTER OF SUSPENSION MAILED
Monday, July 26, 2021SUSPENSION LETTER WRITTEN
Saturday, July 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 20, 2021REFUSAL PROCESSED BY IB
Wednesday, June 2, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 2, 2021REFUSAL PROCESSED BY MPU
Monday, May 31, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, May 30, 2021NON-FINAL ACTION WRITTEN
Monday, May 24, 2021ASSIGNED TO EXAMINER
Tuesday, January 19, 2021APPLICATION FILING RECEIPT MAILED
Thursday, January 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 13, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, January 1, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB